Abstract:
Summary
Superficial bladder cancer (stage Ta-T1) is associated with a high recurrence and progression
rate with implications for patient's survival and quality of live. A better understanding of the disease
natural history may improve the outcome in superficial bladder cancer patients. The information
was gathered from MEDLINE, current urology Journals, abstracts from recent urological meetings and
personal experience. Initial treatment consists of complete transurethral resection, tumor bed cold
cup biopsy with subsequent vaporization, and adjuvant treatment with intravesical instillation of
bacillus Calmefte-Guerin (BCG) or interferon a-2b. Fluorescent cystoscopy, second look TUR allow to
decrease risk of progression and recurrence. Early diagnosis and accurate pathological assessment
are essential for determining the most adequate treatment strategy.
